# Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation

> **NCT01150162** · PHASE3 · COMPLETED · sponsor: **Otsuka Pakistan Limited** · enrollment: 129 (actual)

## Conditions studied

- Gastric Ulcer

## Interventions

- **DRUG:** Rebamipide and Omeprazole
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT01150162
- **Lead sponsor:** Otsuka Pakistan Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-06
- **Final completion:** 2012-08
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2013-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150162, "Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01150162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*